Neurogene Inc (NGNE)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -27.642 | -37.916 | -33.611 | -61.825 | -18.614 | -32.475 | -41.228 | -21.456 |
Return on Equity (%) | -29.241 | -41.209 | -36.821 | -64.79 | -19.992 | -36.334 | -48.531 | -25.908 |
Return on Invested Capital (%) | -45.732 | -52.981 | -38.172 | -66.054 | -20.255 | -36.621 | -50.289 | -39.938 |
Operating Margin (%) | N/A | N/A | -126.324 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -126.34 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 4.892 | 3.339 | 2.448 | 3.197 | 3.948 | 2.937 | 1.933 | 11.967 |
Earnings Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
Cash Per Share | 1.092 | 1.757 | 2.592 | 3.242 | 3.983 | 2.931 | 0.776 | 9.534 |
Working Capital Per Share | 3.178 | 3.304 | 2.444 | 3.145 | 3.861 | 2.785 | 1.805 | 11.41 |
Operating Profit Per Share | N/A | N/A | 0.842 | N/A | 0.162 | N/A | N/A | N/A |
EBIT Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
EBITDA Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
Free Cash Flow Per Share | -1.227 | -1.678 | -1.062 | -1.561 | -0.659 | -1.208 | -1.189 | -2.528 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 10.871 | 9.918 | 16.677 | 30.275 | 24.657 | 16.673 | 8.962 | 8.721 |
Quick Ratio | 10.827 | 9.851 | 16.626 | 30.169 | 24.408 | 16.497 | 8.713 | 8.582 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 23.42M | 23.47M | 23.54M | 38M | 42.2M | 42.46M | 42.65M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 42.58M | 42.6M | 42.65M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 11.967 | N/A | N/A | N/A | 14.735 |
Quick Ratio | N/A | N/A | N/A | 11.66 | N/A | N/A | N/A | 14.345 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 581.91M |
Price to Earnings Ratio | -1.25 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.31 |
Price to Book Ratio | 0.24 |
Dividend Yield | - |
Shares Outstanding | 12.98M |
Average Volume (1 week) | 133.18k |
Average Volume (1 Month) | 128k |
52 Week Change | 183.80% |
52 Week High | 53.00 |
52 Week Low | 12.49 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.